Beyond Sudden Death: New Risk Markers in Hypertrophic Cardiomyopathy

Drs. Owens and de Feria review emerging data on epicardial adipose tissue and MRI-based markers to refine hypertrophic cardiomyopathy risk assessment. They highlight integrating imaging and biomarkers, including NT‑proBNP, to predict heart failure and arrhythmic outcomes.